Announcements Trials
Browse Landscape

Phase

Phase 2 55Phase 3 8Phase 4 5Phase 2/3 3Phase 1 3Phase NA 2Phase 1/2 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Radiation Injuries 1Non-squamous Non-small Cell Lung Cancer 1Lung Neoplasms 1

Interventions

Exercise 440Blood Specimen Collection 335Standard of Care 325Magnetic Resonance Spectroscopy 260Radiotherapy 255Surveys and Questionnaires 246Radiosurgery 245Methods 231Educational Status 231Early Intervention, Educational 219Interviews as Topic 149Practice Guidelines as Topic 147Biopsy 146Surgical Procedures, Operative 136Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 111Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 96Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Specimen Handling 83Radiotherapy, Intensity-Modulated 79Colonoscopy 79Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × endostar protein × Clear all
NCT04274270 2020-03-19

SBRTLCES

Peking University Third Hospital

Phase NA Unknown
60 enrolled
Thoracic

Lung Neoplasms, Radiation Injuries

NCT04063449 2019-08-21

Endostar/PD-1 Inhibitors Combined With PP for Advanced NSCLC

Third Military Medical University

Phase NA Unknown
170 enrolled
Thoracic

Non-squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡